Only qualified healthcare providers may order

Whole Genome Sequencing

The Clinical Services Lab, LLC at HudsonAlpha provides clinical whole genome sequencing of a sample at 30x coverage depth, complete with clinical data interpretation to provide guidance to patients and medical providers. Coverage refers to the number of data reads that are sequenced to ensure a mean coverage of 30x. Contact the laboratory if a 40x coverage or beyond is desired.

This test(s) was developed, and performance characteristics were determined by the HudsonAlpha Clinical Services Lab, LLC. The U.S. Food and Drug Administration (FDA) has not approved or cleared this test; however, FDA clearance or approval is not currently required for clinical use. These tests are used for clinical purposes, and therefore validation was done as required under the requirements of the Clinical Laboratory Improvement Act (CLIA) of 1988. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions. The chance of a false negative or a false-positive result due to laboratory error cannot be completely excluded. These results should not be regarded as investigational or for research.